SVB Leerink and Medical Research

Selected healthcare news for the capital firm - SVB Leerink, and the healthcare topic - Medical Research. We have 436 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/11/2022 FY2021 Earnings Forecast for Bruker Co. (NASDAQ:BRKR) Issued By SVB Leerink Bruker Co. (NASDAQ:BRKR) ‚Ai Research analysts at SVB Leerink lifted their FY2021 earnings estimates for shares of Bruker in a note issued to investors on Friday, January 7th. SVB Leerink analyst P. Souda now forecasts that the medical research company will post earnings of $2.09 per share for the year, up from their prior estimate of $2.07. SVB Leerink also issued estimates for Bruker‚Aos FY2023 earnings at $2.59 ...
1/10/2022 Agilent Technologies, Inc. (NYSE:A) to Post Q2 2022 Earnings of $1.15 Per Share, SVB Leerink Forecasts Agilent Technologies, Inc. (NYSE:A) ‚Ai Analysts at SVB Leerink lifted their Q2 2022 earnings per share (EPS) estimates for shares of Agilent Technologies in a research report issued to clients and investors on Friday, January 7th. SVB Leerink analyst P. Souda now anticipates that the medical research company will post earnings of $1.15 per share for the quarter, up from their prior forecast of $1.14. SVB Leerink currently has ...
1/10/2022 Q2 2022 EPS Estimates for Agilent Technologies, Inc. (NYSE:A) Increased by SVB Leerink - WKRB News Agilent Technologies, Inc. (NYSE:A) ‚Ai SVB Leerink lifted their Q2 2022 earnings per share estimates for Agilent Technologies in a note issued to investors on Friday, January 7th. SVB Leerink analyst P. Souda now anticipates that the medical research company will post earnings per share of $1.15 for the quarter, up from their prior estimate of $1.14. SVB Leerink has a ‚AuOutperform‚Au rating and a $175.00 price objective ...
1/10/2022 Credit Suisse Group Raises Edwards Lifesciences (NYSE:EW) Price Target to $140.00 Edwards Lifesciences (NYSE:EW) had its price target boosted by Credit Suisse Group from $131.00 to $140.00 in a research report report published on Friday, Price Targets.com reports. They currently have an outperform rating on the medical research company‚Aos stock.A number of other analysts have also recently commented on EW. SVB Leerink boosted their target price on shares of Edwards Lifesciences from $130.00 to $135.00 and gave the ...
1/5/2022 Amgen (NASDAQ:AMGN) Lowered to Neutral at Bank of America ... a research note issued to investors on Wednesday, The Fly reports. They presently have a $255.00 price target on the medical research company‚Aos stock, down from their prior price target of $285.00. Bank of ... the stock in a report on Monday, November 1st. Finally, SVB Leerink lowered their target price on shares of Amgen from $234.00 to $216.00 and set a ‚Aumarket perform‚Au rating on the stock in ...
12/21/2021 Edwards Lifesciences (NYSE:EW) Upgraded to Overweight at JPMorgan Chase & Co. - Stock Observer ... medical research company‚Aos stock, up from their prior target price of $114.00.A number of other brokerages have also weighed in on EW. Citigroup upgraded shares of Edwards Lifesciences from a neutral rating to a buy rating and boosted their target price for the company from $120.00 to $142.00 in a research note on Wednesday, December 15th. SVB Leerink upped their price objective on Edwards Lifesciences from $130.00 to ...
12/12/2021 Edwards Lifesciences (NYSE:EW) Earns Outperform Rating from Analysts at Royal Bank of Canada ... medical research company‚Aos stock.EW has been the topic of several other research reports. Credit Suisse Group raised their target price on shares of Edwards Lifesciences from $126.00 to $130.00 and gave the company an outperform rating in a research note on Thursday, October 28th. SVB Leerink raised their target price on shares of Edwards Lifesciences from $130.00 to $135.00 and gave the company an outperform rating in a ...
10/19/2021 Cowen Initiates Coverage on Natera (NASDAQ:NTRA) - Slater Sentinel ... on Friday morning, Analyst Ratings Network reports. The firm issued an outperform rating and a $150.00 target price on the medical research company‚Aos stock.Other research analysts have also issued research reports about the ... outperform rating in a research note on Friday, August 6th. SVB Leerink upped their price objective on shares of Natera from $140.00 to $160.00 and gave the stock an outperform rating in a report on ...
10/19/2021 Equities Analysts Set Expectations for Amgen Inc.'s Q4 2021 Earnings (NASDAQ:AMGN) - Ticker Report Ticker Report ... Amgen in a research note issued on Friday, October 15th. Jefferies Financial Group analyst M. Yee now forecasts that the medical research company will earn $4.06 per share for the quarter, down from their previous ... the company in a research note on Tuesday, June 29th. SVB Leerink assumed coverage on Amgen in a research note on Sunday, September 19th. They issued a ‚Auhold‚Au rating for the company. Morgan Stanley ...
10/18/2021 Amgen Inc. (NASDAQ:AMGN) to Post Q4 2021 Earnings of $4.06 Per Share, Jefferies Financial Group Forecasts ... report issued to clients and investors on Friday, October 15th. Jefferies Financial Group analyst M. Yee now anticipates that the medical research company will post earnings of $4.06 per share for the quarter, down from ... of Amgen in a research note on Friday, September 17th. SVB Leerink started coverage on shares of Amgen in a research note on Sunday, September 19th. They issued a ‚Auhold‚Au rating for the company ...
10/18/2021 Research Analysts Issue Forecasts for Amgen Inc.'s FY2021 Earnings (NASDAQ:AMGN) ... research report issued to clients and investors on Friday, October 15th. Cantor Fitzgerald analyst A. Young now forecasts that the medical research company will post earnings per share of $16.73 for the year, up from ... of Amgen in a research report on Friday, September 17th. SVB Leerink initiated coverage on shares of Amgen in a research report on Sunday, September 19th. They issued a ‚Auhold‚Au rating for the company ...
10/16/2021 Amgen (NASDAQ:AMGN) PT Lowered to $235.00 at Morgan Stanley ... a report issued on Tuesday morning, Analyst Ratings Network reports. The brokerage currently has an equal weight rating on the medical research company‚Aos stock. Other analysts have also recently issued research reports about the ... hold rating and a $222.00 price objective on the stock. SVB Leerink initiated coverage on Amgen in a report on Sunday, September 19th. They set a hold rating on the stock. Finally, William Blair restated ...
9/26/2021 Reviewing Meridian (NASDAQ:MRBK) & Pinnacle Financial Partners (NASDAQ:PNFP) | Daily Political Daily Political Thermo Fisher Scientific (NYSE:TMO) had its price target increased by BTIG Research from $610.00 to $700.00 in a research note published on Wednesday morning, The Fly reports. The firm currently has a buy rating on the medical research company‚Aos stock.Other equities research analysts have also recently issued research reports about the stock. SVB Leerink increased their target price on shares of Thermo Fisher Scientific from $600.00 to $675.00 ...
9/26/2021 Cowen Boosts Thermo Fisher Scientific (NYSE:TMO) Price Target to $655.00 ... 655.00 in a research note published on Thursday morning, The Fly reports. Cowen currently has an outperform rating on the medical research company‚Aos stock. TMO has been the topic of a number of other ... a neutral rating in a report on Monday, September 20th. SVB Leerink lifted their target price on shares of Thermo Fisher Scientific from $600.00 to $675.00 and gave the company an outperform rating in a ...
9/25/2021 UBS Group Increases Thermo Fisher Scientific (NYSE:TMO) Price Target to $670.00 ... to $670.00 in a report released on Tuesday morning, The Fly reports. They currently have a buy rating on the medical research company‚Aos stock. Other analysts have also issued research reports about the stock ... stock. in a research report on Monday, July 12th. Finally, SVB Leerink boosted their price target on shares of Thermo Fisher Scientific from $600.00 to $675.00 and gave the company an outperform rating in a ...
9/25/2021 Thermo Fisher Scientific (NYSE:TMO) PT Raised to $655.00 - Stock Observer ... research note issued to investors on Thursday, The Fly reports. The firm presently has an ‚Auoutperform‚Au rating on the medical research company‚Aos stock. Cowen‚Aos target price suggests a potential upside of 7.42 ... 15th. They noted that the move was a valuation call. SVB Leerink increased their price target on shares of Thermo Fisher Scientific from $600.00 to $675.00 and gave the company an ‚Auoutperform‚Au rating in ...
9/24/2021 Q3 2021 EPS Estimates for Thermo Fisher Scientific Inc. (NYSE:TMO) Raised by Analyst Thermo Fisher Scientific Inc. (NYSE:TMO) ‚Ai Equities research analysts at SVB Leerink boosted their Q3 2021 earnings estimates for shares of Thermo Fisher Scientific in a report issued on Monday, September 20th. SVB Leerink analyst P. Souda now anticipates that the medical research company will earn $4.63 per share for the quarter, up from their previous estimate of $4.51. SVB Leerink has a ‚AuOutperform‚Au rating and a $675.00 ...
9/22/2021 Amgen (NASDAQ:AMGN) Research Coverage Started at SVB Leerink The Markets Daily SVB Leerink began coverage on shares of Amgen (NASDAQ:AMGN) in a research report report published on Sunday, Price Targets.com reports. The brokerage issued a hold rating on the medical research company‚Aos stock. A number of other research firms have also issued reports on AMGN. Morgan Stanley lowered Amgen from an overweight rating to an equal weight rating and lowered their target price for the company from $280.00 to ...
9/22/2021 FY2021 Earnings Estimate for Thermo Fisher Scientific Inc. Issued By SVB Leerink (NYSE:TMO) - Watch List News Thermo Fisher Scientific Inc. (NYSE:TMO) ‚Ai SVB Leerink raised their FY2021 EPS estimates for Thermo Fisher Scientific in a report issued on Monday, September 20th. SVB Leerink analyst P. Souda now expects that the medical research company will post earnings per share of $22.18 for the year, up from their prior estimate of $22.08. SVB Leerink has a ‚AuOutperform‚Au rating and a $675.00 price target on the stock ...
9/22/2021 SVB Leerink Brokers Lift Earnings Estimates for Thermo Fisher Scientific Inc. (NYSE:TMO) - Ticker Report Ticker Report Thermo Fisher Scientific Inc. (NYSE:TMO) ‚Ai Equities research analysts at SVB Leerink raised their FY2021 earnings per share (EPS) estimates for Thermo Fisher Scientific in a report issued on Monday, September 20th. SVB Leerink analyst P. Souda now forecasts that the medical research company will post earnings per share of $22.18 for the year, up from their previous forecast of $22.08. SVB Leerink currently has a ‚AuOutperform‚Au rating ...
9/22/2021 Q3 2021 EPS Estimates for Thermo Fisher Scientific Inc. Increased by SVB Leerink (NYSE:TMO) - Ticker Report Ticker Report Thermo Fisher Scientific Inc. (NYSE:TMO) ‚Ai Investment analysts at SVB Leerink lifted their Q3 2021 EPS estimates for shares of Thermo Fisher Scientific in a note issued to investors on Monday, September 20th. SVB Leerink analyst P. Souda now anticipates that the medical research company will earn $4.63 per share for the quarter, up from their prior estimate of $4.51. SVB Leerink has a ‚AuOutperform‚Au rating and a ...
9/22/2021 Q3 2021 EPS Estimates for Thermo Fisher Scientific Inc. Increased by SVB Leerink (NYSE:TMO) - Watch List News Thermo Fisher Scientific Inc. (NYSE:TMO) ‚Ai Equities research analysts at SVB Leerink raised their Q3 2021 earnings per share estimates for Thermo Fisher Scientific in a report issued on Monday, September 20th. SVB Leerink analyst P. Souda now expects that the medical research company will post earnings per share of $4.63 for the quarter, up from their previous estimate of $4.51. SVB Leerink currently has a ‚AuOutperform‚Au rating ...
9/22/2021 Q3 2021 EPS Estimates for Thermo Fisher Scientific Inc. Increased by SVB Leerink (NYSE:TMO) American Banking News Thermo Fisher Scientific Inc. (NYSE:TMO) ‚Ai Investment analysts at SVB Leerink lifted their Q3 2021 EPS estimates for shares of Thermo Fisher Scientific in a note issued to investors on Monday, September 20th. SVB Leerink analyst P. Souda now anticipates that the medical research company will earn $4.63 per share for the quarter, up from their prior estimate of $4.51. SVB Leerink has a ‚AuOutperform‚Au rating and a ...
9/22/2021 Amgen (NASDAQ:AMGN) Now Covered by SVB Leerink - Mayfield Recorder Mayfield Recorder SVB Leerink initiated coverage on shares of Amgen (NASDAQ:AMGN) in a report issued on Sunday, Analyst Price Targets reports. The brokerage issued a hold rating on the medical research company‚Aos stock.AMGN has been the subject of several other reports. Oppenheimer upped their target price on shares of Amgen from $272.00 to $277.00 and gave the stock an outperform rating in a research report on Monday, June 7th ...
9/22/2021 Thermo Fisher Scientific Inc. to Post FY2022 Earnings of $21.35 Per Share, KeyCorp Forecasts (NYSE:TMO) - Watch List News ... Thermo Fisher Scientific in a research report issued on Sunday, September 19th. KeyCorp analyst P. Knight now anticipates that the medical research company will earn $21.35 per share for the year, up from their previous ... other equities research analysts have also recently commented on TMO. SVB Leerink increased their target price on Thermo Fisher Scientific from $600.00 to $675.00 and gave the company an ‚Auoutperform‚Au rating in a report ...